Management of Refractory Ascites Due to Portal Hypertension: Current Status
David C. Madoff, Joshua Cornman‐Homonoff, Brett E. Fortune, Ron C. Gaba, Andrew J. Lipnik, Hooman Yarmohammadi, Charles E. Ray
Abstract
Refractory ascites is a costly and debilitating condition that occurs most frequently in the setting of substantial cirrhotic portal hypertension, where it portends a poor prognosis. Many treatment options are available, among them medical management, serial large volume paracenteses, transjugular intrahepatic portosystemic shunts, and implanted drainage devices. Although the availability of multiple therapies ensures that most patients will achieve satisfactory results, it can be challenging for the provider to select the appropriate treatment for each specific patient. This article reviews the available therapeutic options for refractory ascites and incorporates available data and clinical experience to suggest a linear stepwise management approach to enhance patient outcomes.